Coverage varies significantly by region and employer opt-inFEHB/PSHB and some large employer groups may have better access
Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies specifically for making claims that implied sameness with FDA-approved products
However, the restrictions around taking oral semaglutide are burdensome
25 Comparability to Other Methods: The percentage of lean mass lost with GLP-1s often falls within the range observed with other effective weight loss methods, including very low-calorie diets and bariatric surgery
These companies have a strong presence in the region, with extensive distribution networks and robust marketing strategies, which support market growth in the country
They also differ in their inactive ingredients and are not interchangeable drugs